{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper links the p.Ala53Thr mutation to PD pathogenesis through epigenetic silencing of the mutated allele, leading to altered SNCA expression.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 2: Evaluate applicability of assays",
          "extracted_paper_info": "The study uses gene expression analysis (mRNA levels) and epigenetic analysis (histone modifications) to assess the mutation's impact.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3: Validity of assays",
          "extracted_paper_info": "The study includes controls (normal alleles in controls) and compares the patient's heterozygous state to matching controls.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3c: Variant controls",
          "extracted_paper_info": "The patient's heterozygous state provides variant controls (mutated and wild-type alleles).",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The mutated allele is epigenetically silenced (histone modifications), and the wild-type allele exhibits higher mRNA levels than both normal alleles in controls.",
          "judgment": "Yes"
        }
      ],
      "evidence_strength": "PS3_supporting"
    }
  ]
}